AAAAAA

   
Results: 1-25 | 26-47
Results: 1-25/47
Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine
Authors: Harro, CD Pang, YYS Roden, RBS Hildesheim, A Wang, ZH Reynolds, MJ Mast, TC Robinson, R Murphy, BR Karron, RA Dillner, J Schiller, JT Lowy, DR
Citation: Cd. Harro et al., Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine, J NAT CANC, 93(4), 2001, pp. 284-292
Construction of a live-attenuated bivalent vaccine virus against human parainfluenza virus (PIV) types 1 and 2 using a recombinant PIV3 backbone
Authors: Tao, T Skiadopoulos, MH Davoodi, F Surman, SR Collins, PL Murphy, BR
Citation: T. Tao et al., Construction of a live-attenuated bivalent vaccine virus against human parainfluenza virus (PIV) types 1 and 2 using a recombinant PIV3 backbone, VACCINE, 19(27), 2001, pp. 3620-3631
Current research on respiratory viral infections: Third International Symposium
Authors: Schmidt, AC Couch, RB Galasso, GJ Hayden, FG Mills, J Murphy, BR Chanock, RM
Citation: Ac. Schmidt et al., Current research on respiratory viral infections: Third International Symposium, ANTIVIR RES, 50(3), 2001, pp. 157-196
Granulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cells
Authors: Bukreyev, A Belyakov, IM Berzofsky, JA Murphy, BR Collins, PL
Citation: A. Bukreyev et al., Granulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cells, J VIROLOGY, 75(24), 2001, pp. 12128-12140
A chimeric human-bovine parainfluenza virus type 3 expressing measles virus hemagglutinin is attenuated for replication but is still immunogenic in rhesus monkeys
Authors: Skiadopoulos, MH Surman, SR Riggs, JM Collins, PL Murphy, BR
Citation: Mh. Skiadopoulos et al., A chimeric human-bovine parainfluenza virus type 3 expressing measles virus hemagglutinin is attenuated for replication but is still immunogenic in rhesus monkeys, J VIROLOGY, 75(21), 2001, pp. 10498-10504
Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in Vero cells or human liver cells and attenuated in mice
Authors: Blaney, JE Johnson, DH Firestone, CY Hanson, CT Murphy, BR Whitehead, SS
Citation: Je. Blaney et al., Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in Vero cells or human liver cells and attenuated in mice, J VIROLOGY, 75(20), 2001, pp. 9731-9740
Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3
Authors: Schmidt, AC McAuliffe, JM Murphy, BR Collins, PL
Citation: Ac. Schmidt et al., Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3, J VIROLOGY, 75(10), 2001, pp. 4594-4603
Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines
Authors: Crowe, JE Firestone, CY Murphy, BR
Citation: Je. Crowe et al., Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines, J IMMUNOL, 167(7), 2001, pp. 3910-3918
Active magnetic bearings for energy storage systems for combat vehicles
Authors: Pichot, MA Kajs, JP Murphy, BR Ouroua, A Rech, BM Hayes, RJ Beno, JH Buckner, GD Palazzolo, AB
Citation: Ma. Pichot et al., Active magnetic bearings for energy storage systems for combat vehicles, IEEE MAGNET, 37(1), 2001, pp. 318-323
Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3 '-untranslated region
Authors: Durbin, AP Karron, RA Sun, W Vaughn, DW Reynolds, MJ Perreault, JR Thumar, B Men, R Lai, CJ Elkins, WR Chanock, RM Murphy, BR Whitehead, SS
Citation: Ap. Durbin et al., Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3 '-untranslated region, AM J TROP M, 65(5), 2001, pp. 405-413
A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission fromvaccinees to mosquitoes
Authors: Troyer, JM Hanley, KA Whitehead, SS Strickman, D Karron, RA Durbin, AP Murphy, BR
Citation: Jm. Troyer et al., A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission fromvaccinees to mosquitoes, AM J TROP M, 65(5), 2001, pp. 414-419
Sequence determination and molecular analysis of two strains of bovine parainfluenza virus type 3 that are attenuated for primates
Authors: Bailly, JE McAuliffe, JM Skiadopoulos, MH Collins, PL Murphy, BR
Citation: Je. Bailly et al., Sequence determination and molecular analysis of two strains of bovine parainfluenza virus type 3 that are attenuated for primates, VIRUS GENES, 20(2), 2000, pp. 173-182
African green monkeys provide a useful nonhuman primate model for the study of human parainfluenza virus types-1,-2, and-3 infection
Authors: Durbin, AP Elkins, WR Murphy, BR
Citation: Ap. Durbin et al., African green monkeys provide a useful nonhuman primate model for the study of human parainfluenza virus types-1,-2, and-3 infection, VACCINE, 18(22), 2000, pp. 2462-2469
Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults
Authors: Gonzalez, IM Karron, RA Eichelberger, M Walsh, EE Delagarza, VW Bennett, R Chanock, RM Murphy, BR Clements-Mann, ML Falsey, AR
Citation: Im. Gonzalez et al., Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults, VACCINE, 18(17), 2000, pp. 1763-1772
A live attenuated recombinant chimeric parainfluenza virus (PIV) candidatevaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to PIV3
Authors: Tao, T Davoodi, F Cho, CJ Skiadopoulos, MH Durbin, AP Collins, PL Murphy, BR
Citation: T. Tao et al., A live attenuated recombinant chimeric parainfluenza virus (PIV) candidatevaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to PIV3, VACCINE, 18(14), 2000, pp. 1359-1366
Comparison of identical temperature-sensitive mutations in the L polymerase proteins of Sendai and parainfluenza3 viruses
Authors: Feller, JA Smallwood, S Skiadopoulos, MH Murphy, BR Moyer, SA
Citation: Ja. Feller et al., Comparison of identical temperature-sensitive mutations in the L polymerase proteins of Sendai and parainfluenza3 viruses, VIROLOGY, 276(1), 2000, pp. 190-201
Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes
Authors: Skiadopoulos, MH Surman, SR Durbin, AP Collins, PL Murphy, BR
Citation: Mh. Skiadopoulos et al., Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes, VIROLOGY, 272(1), 2000, pp. 225-234
A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is at attenuated in primates
Authors: Bailly, JE McAuliffe, JM Durbin, AP Elkins, WR Collins, PL Murphy, BR
Citation: Je. Bailly et al., A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is at attenuated in primates, J VIROLOGY, 74(7), 2000, pp. 3188-3195
Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): Effects on host rangeand evaluation as a live-attenuated HRSV vaccine
Authors: Buchholz, UJ Granzow, H Schuldt, K Whitehead, SS Murphy, BR Collins, PL
Citation: Uj. Buchholz et al., Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): Effects on host rangeand evaluation as a live-attenuated HRSV vaccine, J VIROLOGY, 74(3), 2000, pp. 1187-1199
Respiratory syncytial virus can tolerate an intergenic sequence of at least 160 nucleotides with little effect on transcription or replication in vitro and in vivo
Authors: Bukreyev, A Murphy, BR Collins, PL
Citation: A. Bukreyev et al., Respiratory syncytial virus can tolerate an intergenic sequence of at least 160 nucleotides with little effect on transcription or replication in vitro and in vivo, J VIROLOGY, 74(23), 2000, pp. 11017-11026
Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates
Authors: Schmidt, AC McAuliffe, JM Huang, A Surman, SR Bailly, JE Elkins, WR Collins, PL Murphy, BR Skiadopoulos, MH
Citation: Ac. Schmidt et al., Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates, J VIROLOGY, 74(19), 2000, pp. 8922-8929
Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees
Authors: Teng, MN Whitehead, SS Bermingham, A St Claire, M Elkins, WR Murphy, BR Collins, PL
Citation: Mn. Teng et al., Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees, J VIROLOGY, 74(19), 2000, pp. 9317-9321
Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy
Authors: Durbin, AP Skiadopoulos, MH McAuliffe, JM Riggs, JM Surman, SR Collins, PL Murphy, BR
Citation: Ap. Durbin et al., Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy, J VIROLOGY, 74(15), 2000, pp. 6821-6831
Effect of coexpression of interleukin-2 by recombinant respiratory syncytial virus on virus replication, immunogenicity, and production of other cytokines
Authors: Bukreyev, A Whitehead, SS Prussin, C Murphy, BR Collins, PL
Citation: A. Bukreyev et al., Effect of coexpression of interleukin-2 by recombinant respiratory syncytial virus on virus replication, immunogenicity, and production of other cytokines, J VIROLOGY, 74(15), 2000, pp. 7151-7157
Replacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates
Authors: Tao, T Skiadopoulos, MH Davoodi, F Riggs, JM Collins, PL Murphy, BR
Citation: T. Tao et al., Replacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates, J VIROLOGY, 74(14), 2000, pp. 6448-6458
Risultati: 1-25 | 26-47